In a trial, relacorilant significantly reduced the likelihood of hypertension response loss among patients with endogenous hypercortisolism.
Morning Overview on MSN
RNA-guided CRISPR tool turns genes on with dose control
Researchers have built a series of CRISPR-based platforms that can switch endogenous genes on and, just as critically, dial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results